-
N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride
-
ChemBase ID:
154844
-
Molecular Formular:
C24H27Cl3FN5O3
-
Molecular Mass:
558.8602832
-
Monoisotopic Mass:
557.11635101
-
SMILES and InChIs
SMILES:
C=CC(=O)Nc1cc2c(cc1OCCCN1CCOCC1)ncnc2Nc1ccc(c(c1)Cl)F.Cl.Cl
Canonical SMILES:
C=CC(=O)Nc1cc2c(ncnc2cc1OCCCN1CCOCC1)Nc1ccc(c(c1)Cl)F.Cl.Cl
InChI:
InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H
InChIKey:
JZZFDCXSFTVOJY-UHFFFAOYSA-N
-
Cite this record
CBID:154844 http://www.chembase.cn/molecule-154844.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride
|
|
|
IUPAC Traditional name
|
canertinib dihydrochloride
|
|
|
Synonyms
|
PD183805
|
CI-1033
|
Canertinib dihydrochloride
|
N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide dihydrochloride
|
N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide dihydrochloride
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
12.538747
|
H Acceptors
|
7
|
H Donor
|
2
|
LogD (pH = 5.5)
|
2.4924963
|
LogD (pH = 7.4)
|
3.7905312
|
Log P
|
3.9026284
|
Molar Refractivity
|
130.5543 cm3
|
Polarizability
|
49.885162 Å3
|
Polar Surface Area
|
88.61 Å2
|
Rotatable Bonds
|
9
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
C7249
|
Biochem/physiol Actions CI-1033 is a potent, irreversible ATP binding site-directed pan-ErbB tyrosine kinase inhibitor with IC50 in the low nanomolar range for EGFR, HER2, and ErbB-4. |
PATENTS
PATENTS
PubChem Patent
Google Patent